HC Wainwright & Co. analyst Mike Colonnese maintains HIVE Blockchain Techs (NASDAQ:HIVE) with a Buy and maintains $5 price target.
Home Newsfeeds HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Maintains $5 Price Target
HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Maintains $5 Price Target
HC Wainwright & Co. analyst Mike Colonnese maintains HIVE Blockchain Techs (NASDAQ:HIVE) with a Buy and maintains $5 price target.
Related Posts
RVL Pharmaceuticals plc Announces Result Of Proposal To Approve A Waiver Of Offer Obligations Under Rule 9 Of The Irish Takeover Rules At Annual General Meeting
June 15, 4:21 PM
RVL Pharmaceuticals plc (NASDAQ:RVLP) ("RVL" or the "Company"), a specialty pharmaceutical company, today announced results of the proposal to approve a waiver of offer obligations under Rule 9 of the Irish Takeover
What 10 Analyst Ratings Have To Say About Sunrun
January 10, 4:00 PM
Over the past 3 months, 10 analysts have published their opinion on Sunrun (NASDAQ:RUN) stock. These analysts are…
Top 3 Consumer Stocks That May Rocket Higher This Quarter
March 27, 8:40 AM
The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies.